L

L Operating Cash Flow (Statement)

$2.76BTTM · USD

Period ending:

L FY Cash from OperationsUSD
L FY Cash from Operations1989-12-31: $1.91B1990-12-31: $2.31B1991-12-31: $2.72B1992-12-31: $1.69B1993-12-31: $1.66B1994-12-31: $1.50B1995-12-31: $1.30B1996-12-31: $943.70M1997-12-31: $243.80M1998-12-31: -$236.20M1999-12-31: -$2.07B2000-12-31: -$438.80M2001-12-31: $539.00M2002-12-31: $1.79B2003-12-31: $2.78B2004-12-31: $2.82B2005-12-31: $3.37B2006-12-31: $1.71B2007-12-31: $5.67B2008-12-31: $3.37B2009-12-31: $4.59B2010-12-31: $43.00M2011-12-31: $3.97B2012-12-31: $2.85B2013-12-31: $2.10B2014-12-31: $2.99B2015-12-31: $3.55B2016-12-31: $2.25B2017-12-31: $2.59B2018-12-31: $4.22B2019-12-31: $1.74B2020-12-31: $1.75B2021-12-31: $2.62B2022-12-31: $3.31B2023-12-31: $3.91B2024-12-31: $3.03B2025-12-31: $3.28B$5.67B-$2.07B
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

L operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Loews Corporation Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
3,279,000,000
3,025,000,000
3,907,000,000
3,314,000,000
2,623,000,000
1,745,000,000
1,741,000,000
4,222,000,000
2,590,000,000
2,253,000,000
3,547,000,000
2,990,000,000
2,096,000,000
2,854,000,000
3,965,000,000
43,000,000
4,591,000,000
3,371,000,000
5,671,000,000
1,714,700,000
3,367,100,000
2,821,100,000
2,783,800,000
1,789,200,000
539,000,000
-438,800,000
-2,068,400,000
-236,200,000
243,800,000
943,700,000
1,295,900,000
1,499,300,000
1,660,700,000
1,687,400,000
2,715,300,000
2,310,100,000
1,907,500,000

Compare operating cash flow (statement)

All L financial metrics · L stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.